Connection

RAJKUMAR VENKATRAMANI to Drug Industry

This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Drug Industry.
Connection Strength

0.048
  1. Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration. Eur J Cancer. 2021 11; 157:198-213.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.